Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12872 Drug press releases.

Journal of Pharmaceutical Analysis (JPA) Studies Find Promising Drug Candidates

Researchers investigate the intricacies of various cellular processes and pathologies and identify compounds with untapped therapeutic potential XI'AN, China , March 29, 2024 /PRNewswire/ -- Understanding the underlying mechanisms of ...


Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SHANGHAI , March 29, 2024 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic ...

STATEMENT - CMA seriously concerned about the future of family medicine in Quebec

OTTAWA, ON , March 20, 2024 /CNW/ - The Canadian Medical Association (CMA) joins the Fédération des médecins omnipraticiens du Québec (FMOQ) in voicing its concerns about the first round results of the Canadian Resident Matching Service ...

Enhancing National Preparedness: Rafa Laboratories Partners with BARDA to Advance the Development of a new design for Rafa's Pediatric Atropine Autoinjectors

JERUSALEM , March 20, 2024 /PRNewswire/ -- Rafa Laboratories, LTD., a leading manufacturer of Emergency Medical Solutions, and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic ...

American Society of Pharmacovigilance Amplifies Coordinated Efforts on Third Annual National Adverse Drug Event Day

HOUSTON , March 20, 2024 /PRNewswire/ -- Almost one million Americans have died of adverse drug events, many avoidable, in the three year history of National Adverse Drug Event (ADE) Day. The American Society of Pharmacovigilance (ASP) is ...

Everest Medicines Announces Singapore Health Sciences Authority Approves NEFEGAN® for the Treatment of Primary IgA Nephropathy in Adult Patients

SHANGHAI , March 19, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and ...

TrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond

CANTON, Mich. (March 14, 2024) - TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ...

Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates

ZHUHAI, China , March 15, 2024 /PRNewswire/ -- On March 14, 2024 , Biotheus Inc. (Biotheus), a clinical-stage biotech company focusing on the discovery and development of biologics for oncology and inflammatory diseases, and Hansoh ...

Ready for Launch: Coast Smokes and Willie's Remedy Launch Eco-Friendly CBD Hemp Smokes and Vapes

Introducing a cleaner, greener way to enjoy hemp smokeables: Biodegradable hemp filters and rechargeable vape batteries DALLAS , March 14, 2024 /PRNewswire-PRWeb/ -- Coast Smokes collaborates with Willie Nelson's legendary hemp ...

Creating a Better Environment for Remote Drug Testing Results

eRAMx Safeguards Drug Test Integrity with Features for Observation Quality INDIANAPOLIS , March 12, 2024 /PRNewswire/ -- Innovations in remote drug testing technology are allowing observers to actively improve a testing environment, ...

Drug News »

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Biopharmaceutical companies are once again competing in the development of innovative drugs for metabolic dysfunction-associated steatohepatitis (MASH), after a series of failures faced by drug manufacturers. The US FDA approval of ...

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

A study was presented by the Gardy Health system in Atlanta, Georgia, US, at the 73rd Annual Scientific Session of the American College of Cardiology. The study was conducted to evaluate the frequency of heart failure hospitalizations (HFH) in ...

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generic drugs and Branded drugs are essentially the same, as they both have the same active ingredient. Generic drugs can provide the same therapeutic advantages as branded drugs at a reduced cost, as they do not have to undergo extensive ...

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Melanoma is an extremely fatal form of skin cancer and has inherent resistance to both radiotherapy and chemotherapy ( ). The occurrence of Melanoma has been increasing steadily and become a major health issue since the 5-year ...

Marijuana Use for Morning Sickness Risks Mother and Baby Health

Marijuana Use for Morning Sickness Risks Mother and Baby Health

Using marijuana to alleviate nausea and vomiting during pregnancy could harm newborns’ brain development and exacerbate maternal health issues ...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.